Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €65.10 EUR
Change Today +0.46 / 0.71%
Volume 804.8K
As of 11:35 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitleKey Developments
Albrecht De Graeve 49 RelationshipsIndependent Director and Chairman of Audit Committee 
Charles-Antoine Janssen 34 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitle
Diégo du Monceau de Bergendal 35 RelationshipsVice Chairman and Chairman of Governance, Nomination & Compensation Committee
Harriet Edelman 75 RelationshipsIndependent Director and Member of Governance, Nomination & Compensation Committee
Thomas McKillop Ph.D. 132 RelationshipsIndependent Director and Member of Governance, Nomination & Compensation Committee
Key PositionIndustry Range
No Compensation vs Industry data is available for UCB.
52 Week Price Performance
Share price activity for UCB SA (UCB)
UCB
Industry Average

Nominating Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitleKey Developments
Diégo du Monceau de Bergendal 35 RelationshipsVice Chairman and Chairman of Governance, Nomination & Compensation CommitteeBiotie Therapies Corp. and UCB SA Announce Resignation of Peter Fellner as Director
05/8/14
Thomas McKillop Ph.D. 132 RelationshipsIndependent Director and Member of Governance, Nomination & Compensation CommitteeUCB Announces Management Changes
02/21/14
Harriet Edelman 75 RelationshipsIndependent Director and Member of Governance, Nomination & Compensation CommitteeUCB SA Announces Executive Changes
10/17/12

Corporate Governance Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitle
Diégo du Monceau de Bergendal 35 RelationshipsVice Chairman and Chairman of Governance, Nomination & Compensation Committee
Harriet Edelman 75 RelationshipsIndependent Director and Member of Governance, Nomination & Compensation Committee
Thomas McKillop Ph.D. 132 RelationshipsIndependent Director and Member of Governance, Nomination & Compensation Committee
UCB and Competitor
Insiders vs. External
Board
4%
96%
UCB S.A.
10%
90%
Endo International plc
10%
90%
Sigma-Aldrich Corporation
0%
100%
Lonza Group Ltd
31%
69%
Grifols, S.A.
10%
90%
Hospira Inc.
Insiders
External Board Members

Executive Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitle
Michele Antonelli 0 RelationshipsFormer Executive Vice President of European Commercial Operations, Member of Executive Committee, Chairman of The Ucb Farchim Board and Managing Director of Ucb France
Frederic Doliveux DVM 44 RelationshipsHonorary Director
Greg Duncan 20 RelationshipsFormer Executive Vice President and President of North American Operations
Fabrice Enderlin 0 RelationshipsChief Talent Officer
Ismail Kola Ph.D. 69 RelationshipsChief Scientific Officer and Head of New Medicines Patient Value Unit
Iris Löw-Friedrich 9 RelationshipsAd Interim Head of Bone Disorders Patient Value Unit
Mark McDade 53 RelationshipsChief Operating Officer
Jean-Christophe Tellier 26 RelationshipsChief Executive Officer and Executive Director
Detlef Thielgen 5 RelationshipsChief Financial Officer
Robert Trainor 0 RelationshipsFormer Executive Vice President, General Counsel and Member of Executive Committee
Management Effectiveness Relative to the Industry
Return on Equity
0.1x
Return on Assets
0.3x
Return on Total Capital
0.3x
TEV/Total Revenue(LTM)
0.3x
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UCB:BB €65.10 EUR +0.46

UCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Endo International PLC $83.76 USD +0.82
Grifols SA €36.31 EUR -0.84
Hospira Inc $88.42 USD -0.02
Lonza Group AG SFr.132.00 CHF -3.40
Sigma-Aldrich Corp $139.30 USD +0.42
View Industry Companies
 

Industry Analysis

UCB

Industry Average

Valuation UCB Industry Range
Price/Earnings 96.9x
Price/Sales 3.3x
Price/Book 2.2x
Price/Cash Flow 54.4x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UCB SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.